Kavitha Seenivasan
About Kavitha Seenivasan
Kavitha Seenivasan is an Associate Director of Clinical Data Management with extensive experience in clinical research and medical coding. She has worked with several organizations, including Nektar Therapeutics and Allergan, and possesses expertise in Serious Adverse Event reconciliation and database design for clinical trials.
Work at Nektar Therapeutics
Kavitha Seenivasan currently holds the position of Associate Director in Clinical Data Management at Nektar Therapeutics. She has been with the company since 2021, contributing her expertise in managing clinical data processes. Her role involves overseeing data management strategies and ensuring compliance with regulatory standards in clinical trials. Nektar Therapeutics focuses on innovative therapies, and her work supports the company's mission to advance new treatments.
Education and Expertise
Kavitha Seenivasan has a strong educational background in the field of pharmacy and clinical data management. She earned a Bachelor of Pharmacy (B.Pharm) from Kamalakshi Pandurangan College of Pharmacy, affiliated with Dr. M.G.Ramachandra Medical University, from 1995 to 1999. Additionally, she completed a Postgraduate Diploma in Computer Applications (PGDCA) at Students Computer Center in Chennai from 1999 to 2000. She furthered her studies at UC San Diego Extended Studies, achieving certifications in Medical Terminology and Medical Writing, focusing on protocols, reports, summaries, and submissions.
Background in Clinical Data Management
Kavitha Seenivasan has extensive experience in clinical data management, having worked in various roles across multiple organizations. She served as a Safety Specialist in Data Management at Kendle International from 2003 to 2006. Later, she worked at Allergan as a Senior Medical Coding Specialist and then as a Principal Medical Coding Specialist/SAE Reconciliation Data Manager from 2007 to 2015. Her tenure at JenaValve Technology, Inc. as Manager of Clinical Data Management and Medical Coding lasted from 2020 to 2021. She also held the position of Senior Manager at the Parker Institute for Cancer Immunotherapy from 2019 to 2020.
Achievements in Clinical Research
Kavitha Seenivasan has made significant contributions to clinical research, particularly in the areas of Serious Adverse Event (SAE) reconciliation and database design. Her expertise includes advanced knowledge of Dictionary Upversioning processes, ensuring that medical coding dictionaries are updated for compliance and accuracy. She specializes in using WHO Drug Global and MedDRA dictionaries, which are vital for standardizing medical terminology in clinical trials. Her experience spans Phase I-III clinical trials and post-marketing observational research studies.